A patient has been treated with antiparkinson medications for 3 months. What therapeutic responses should the nurse look for when assessing this patient?
Improved ability to perform activities of daily living
Decreased appetite
Newly developed dyskinesias
Gradual development of cogwheel rigidity
The Correct Answer is A
A. Improved ability to perform activities of daily living: Antiparkinson medications are aimed at improving motor symptoms such as tremors, rigidity, and bradykinesia, leading to improved function in activities of daily living.
B. Decreased appetite: Decreased appetite is not a therapeutic response to antiparkinson medications. In fact, some medications may cause weight gain due to increased appetite.
C. Newly developed dyskinesias: Dyskinesias are involuntary movements that can occur as a side effect of long-term treatment with antiparkinson medications, particularly levodopa. They are not a therapeutic response and may require adjustments to medication.
D. Gradual development of cogwheel rigidity: Cogwheel rigidity is a symptom of Parkinson's disease and would not be expected to develop gradually with treatment. Antiparkinson
medications aim to reduce rigidity, not cause it.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["15"]
Explanation
Given:
Amantadine syrup concentration: 50 mg/5 mL Desired dose of amantadine: 150 mg
5ml contains 50mg
1ml contains 50/5= 10mg Given 10mg is in 1ml
Then 150mg will be contained in: 150/10
=15ml
Correct Answer is B
Explanation
A. Diarrhea is not typically associated with ergotamine toxicity. Gastrointestinal symptoms such as nausea and vomiting are more common adverse effects of ergotamine use.
B. Delirium is a potential sign of ergotamine toxicity. At toxic levels, ergotamine can cause central nervous system symptoms such as confusion, hallucinations, and delirium.
C. Hypotension may occur as an adverse effect of ergotamine due to its vasoconstrictive properties. However, hypotension alone may not indicate ergotamine toxicity.
D. Bradycardia is not a typical adverse effect of ergotamine. Ergotamine is more commonly associated with vasoconstriction and can lead to hypertension or tachycardia rather than bradycardia.
A. Diarrhea is not typically associated with ergotamine toxicity. Gastrointestinal symptoms such as nausea and vomiting are more common adverse effects of ergotamine use.
B. Delirium is a potential sign of ergotamine toxicity. At toxic levels, ergotamine can cause central nervous system symptoms such as confusion, hallucinations, and delirium.
C. Hypotension may occur as an adverse effect of ergotamine due to its vasoconstrictive properties. However, hypotension alone may not indicate ergotamine toxicity.
D. Bradycardia is not a typical adverse effect of ergotamine. Ergotamine is more commonly associated with vasoconstriction and can lead to hypertension or tachycardia rather than bradycardia.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.